Cargando…
TGR5 expression in benign, preneoplastic and neoplastic lesions of Barrett’s esophagus: Case series and findings
AIM: To examined the bile acid receptor TGR5 expression in squamous mucosa, Barrett’s mucosa, dysplasia and esophageal adenocarcinoma (EA). METHODS: Slides were stained with TGR5 antibody. The staining intensity was scored as 1+, 2+ and 3+. The extent of staining (percentage of cells staining) was s...
Autores principales: | Marketkar, Shivali, Li, Dan, Yang, Dongfang, Cao, Weibiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330818/ https://www.ncbi.nlm.nih.gov/pubmed/28293080 http://dx.doi.org/10.3748/wjg.v23.i8.1338 |
Ejemplares similares
-
Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix
por: Saavedra, Kathleen P, et al.
Publicado: (2012) -
Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007) -
Aneuploidy Mechanisms in Human Colorectal Preneoplastic Lesions and Barrett’s Esophagus. Is There a Role for K-Ras and p53 Mutations?
por: Giaretti, Walter
Publicado: (1997) -
Preneoplastic and neoplastic gallbladder lesions detected after cholecystectomy
por: Kocaöz, Servet, et al.
Publicado: (2019) -
Dysregulation of PARP1 is involved in development of Barrett’s esophagus
por: Zhang, Chao, et al.
Publicado: (2018)